Skip to content

NA 72202962Recalls & reported problems

Smith & Nephew, Inc. · VIDEOARTHROSCOPE NON-AUTOCLAVABLE, BLACK FOCUS RING, 19.5 MM FOCAL LENGTH, 4.0 MM OUTER DIAMETER X 70 DEGREE DIRECTION OF VIEW, 115 DEGREE FIELD OF VIEW, · Class 2

Adverse event reports
6
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 00885554024166), received between Dec 11, 2018 and Jul 16, 2023 — classified as 6 malfunctions.

The most frequently reported specific device problem is “Crack” (3 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Most reported problems

Device problems

  • Crack3
  • Material Integrity Problem3
  • Optical Obstruction3
  • Break2
  • Misfocusing1
  • Moisture or Humidity Problem1
  • Poor Quality Image1

Patient problems

  • No Clinical Signs, Symptoms or Conditions5
  • Insufficient Information2
  • No Known Impact Or Consequence To Patient1

Recent adverse event reports

The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJul 16, 2023Misfocusing; Material Integrity Problem; Moisture or Humidity Problem; Misfocusing; Material Integrity Problem; Moisture or Humidity Problem

    IT WAS REPORTED THAT DURING A HIP ARTHROSCOPY, THE VIDEO ARTHROSCOPE DID NOT FOCUS. THERE WAS A BACK-UP DEVICE AVAILABLE AND A DELAY GREATER THAN 30 MINUTES WAS REPORTED. NO FURTHER COMPLICATIONS WERE REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 17330930 ↗
  • MalfunctionOct 21, 2022Optical Obstruction; Optical Obstruction

    IT WAS REPORTED THAT DURING USE, THE VIDEO ARTHROSCOPE WAS UNVIEWABLE. THE PROCEDURE WAS COMPLETED WITH A COMPETITOR DEVICE. THERE WAS A SURGICAL DELAY GREATER THAN 30 MINUTES AND NO FURTHER COMPLICATIONS WERE REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 15655902 ↗
  • MalfunctionOct 21, 2022Break; Crack; Material Integrity Problem; Optical Obstruction; Break; Crack; Material Integrity Problem; Optical Obstruction

    IT WAS REPORTED THAT DURING USE, THE VIDEO ARTHROSCOPE WAS UNVIEWABLE. THE PROCEDURE WAS COMPLETED WITH A COMPETITOR DEVICE. THERE WAS A SURGICAL DELAY GREATER THAN 30 MINUTES AND NO FURTHER COMPLICATIONS WERE REPORTED.

    Patient problems: Insufficient Information; No Clinical Signs, Symptoms or Conditions

    MAUDE report 15655462 ↗
  • MalfunctionOct 21, 2022Break; Crack; Material Integrity Problem; Optical Obstruction; Break; Crack; Material Integrity Problem; Optical Obstruction

    IT WAS REPORTED THAT DURING USE, THE VIDEO ARTHROSCOPE WAS UNVIEWABLE. THE PROCEDURE WAS COMPLETED WITH A COMPETITOR DEVICE. THERE WAS A SIGNIFICANT SURGICAL DELAY AND NO FURTHER COMPLICATIONS WERE REPORTED.

    Patient problems: Insufficient Information; No Clinical Signs, Symptoms or Conditions

    MAUDE report 15655407 ↗
  • MalfunctionJan 21, 2021Crack; Crack

    IT WAS REPORTED THAT DURING A HIP CASE THE EXTERNAL LENS OF THE SCOPE WAS CRACKED. NO PATIENT INJURIES OR DELAY REPORTED. SMITH AND NEPHEW BACK-UP DEVICE WAS AVAILABLE TO COMPLETE THE SURGERY. ALL AVAILABLE INFORMATION HAS BEEN DISCLOSED. IF ADDITIONAL INFORMATION SHOULD BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED ACCORDINGLY.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 11208025 ↗
  • MalfunctionDec 11, 2018Poor Quality Image

    IT WAS REPORTED A BAD IMAGE. NO PATIENT INJURY OR SIGNIFICANT DELAY WERE REPORTED. BACK UP DEVICE WAS NOT AVAILABLE.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 8150411 ↗

Other NASOPHARYNGOSCOPE (FLEXIBLE OR RIGID) devices

All NASOPHARYNGOSCOPE (FLEXIBLE OR RIGID) devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.